SCHEMBL1709709

SCHEMBL1709709

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(C#N)n[nH]1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.66
KCNH2 Q12809 3/20 0.35
CCR4 P51679 2/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD1 P21728 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
GAA P10253 1/20 0.35
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
CACNA2D1 P54289 7/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1989820 0.88 GHSR (0.78) GHSRKCNH2CCR4CHRM2HTR1A
SCHEMBL10121964 0.85 GHSR (0.69) GHSRKCNH2CCR4CHRM2HTR1A
SCHEMBL1709708 0.84 GHSR (0.67) GHSRKCNH2CCR4CHRM2HTR1A
SCHEMBL10121926 0.84 GHSR (0.67) GHSRKCNH2CCR4CHRM2HTR1A
SCHEMBL1993074 0.84 GHSR (0.69) GHSRTSHRCNR1CNR2MEN1
SCHEMBL1709649 0.83 GHSR (0.68) GHSRKCNH2CCR4CHRM2HTR1A
SCHEMBL1990507 0.82 GHSR (0.69) GHSRCCR4SLC6A3CNR1CNR2
SCHEMBL1984635 0.82 GHSR (0.69) GHSRCCR4SLC6A3CNR1CNR2
SCHEMBL1709559 0.82 GHSR (0.67) GHSRKCNH2CCR4CHRM2HTR1A
SCHEMBL1981207 0.81 GHSR (0.81) GHSRKCNH2CCR4CHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885KCNH2 2037/4885CCR4 3489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.